Table 5 Testing data set results a
Tumor pathologic variables | Receptors (core biopsy) | Pretreatment hemoglobin parameters | Sensitivity (%)/specificity (%) | PPV (%)/NPV (%) | AUC (%) (95% CI) |
|---|---|---|---|---|---|
IDC/ILC, NS, MC | Â | Â | 51.8/68.1 | 57.9/63.3 | 80.0 (51.11; 99.29) |
IDC/ILC, NS, MC | TN, HER2, ER | Â | 56.8/88.9 | 84.8/70.9 | 84.0 (57.16; 99.03) |
| Â | Â | tHb | 63.2/82.1 | 75.0/72.8 | 87.3 (62.13; 99.82) |
| Â | Â | oxyHb | 60.8/81.9 | 73.6/71.4 | 84.0 (56.01; 100.0) |
| Â | Â | deoxyHb | 52.2/89.6 | 80.4/69.1 | 72.2 (36.55; 97.67) |
| Â | Â | tHb, oxyHb | 64.4/82.1 | 75.2/73.4 | 85.0 (57.61; 99.82) |
| Â | Â | tHb, deoxyHb | 60.7/80.6 | 73.3/70.9 | 79.5 (56.32; 97.82) |
IDC/ILC, NS, MC | TN, HER2, ER | tHb | 78.7/93.6 | 89.5/85.9 | 92.4 (79.42; 99.80) |
IDC/ILC, NS, MC | TN, HER2, ER | oxyHb | 76.9/85.2 | 82.6/83.3 | 90.6 (74.36; 99.35) |
IDC/ILC, NS, MC | TN, HER2, ER | deoxyHb | 60.1/85.0 | 78.4/71.8 | 85.0 (58.78; 98.95) |
IDC/ILC, NS, MC | TN, HER2, ER | tHb, oxyHb | 73.2/84.9 | 81.8/81.7 | 88.6 (72.21; 97.51) |
IDC/ILC, NS, MC | TN, HER2, ER | tHb, deoxyHb | 71.5/84.3 | 79.5/79.1 | 85.0 (63.09; 99.53) |